3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
8
Neoplasms
2
Prostatic Neoplasms, Castration-Resistant
1
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
1
Neoplasm Metastasis
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer
1
Colorectal Neoplasms
1
Castrate Sensitive Prostate Cancer
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Bulbo-Spinal Atrophy, X-Linked
1
Bites and Stings
1
Interventions
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Methotrexate
3
Cytarabine
3
venetoclax
2
ponatinib
2
merphos
2
fludarabine phosphate
2
Tacrolimus
2
Idarubicin
2
Etoposide
2
Cyclosporine
2
Cyclophosphamide
2
Cladribine
2
Busulfan
2
midostaurin
1
gilteritinib
1
blinatumomab
1
Thiotepa
1
Sirolimus
1
Razoxane
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Melphalan
1
Injections
1
Gemtuzumab
1
Dexrazoxane
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blast Crisis
×
abiraterone
×
30 days
×
Clear all
No trials found.